Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07224880 · ClinicalTrials.gov registry record
Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
A clinical trial of Skin Laxity and glp1 Agonist, sponsored by Cytrellis Biosystems.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT07224880: Recruiting study of Skin Laxity and glp1 Agonist, sponsored by Cytrellis Biosystems.
NCT07224880 is a study of Skin Laxity and glp1 Agonist that is actively recruiting participants, run by Cytrellis Biosystems. The registered enrollment target is 10 participants, below the 190-participant average among 10 other Skin Laxity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07224880, a study of Skin Laxity and glp1 Agonist, is actively recruiting participants, sponsored by Cytrellis Biosystems.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of the study is to collect information about how the device functions in a variety of treatment areas and skin types and to find out what changes, if any, occur in the skin treated with the study device compared to the skin that wasn't treated including patients receiving GLP-1's, a class of medications that mimic a natural hormone to help control blood sugar and support weight loss. The study will also evaluate side effects that occur with this treatment, if any. Standardized 2D Imaging will be used to quantify reduction of wrinkle severity
Primary Outcome
Safety and Efficacy of ellacor treatment in participants with FST I-VI, inclusive of participants following treatment with GLP-1 RA There will be follow-up appointments after the initial screening and enrollment visit. Each of the assessments at follow up days are specified below: Baseline or Day 0 Day 3 Day 7 Day 30 through study completion, up to Day 90
Conditions Studied
Interventions
- DEVICE ellacor
Study Locations (1)
California
- Tri Valley Plastic Surgery - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-14 |
| Est. Completion | 2026-02-28 |
What NCT07224880 shows while recruiting
NCT07224880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 190-participant average among 10 other Skin Laxity trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which ellacor is the first listed.
NCT07224880 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07224880 about?
NCT07224880 is a clinical study titled "Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists". The main purpose of the study is to collect information about how the device functions in a variety of treatment areas and skin types and to find out what changes, if any, occur in the skin treated with the study device compared to the skin that wasn't treated including patients receiving GLP-1's, a...
What is the current status of trial NCT07224880?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-10-14. Estimated completion is 2026-02-28.
What conditions does trial NCT07224880 study?
This clinical trial studies the following conditions: Skin Laxity, glp1 Agonist, Gene Expression.
What interventions are being tested in trial NCT07224880?
The interventions under investigation include: ellacor (DEVICE).
Who is sponsoring clinical trial NCT07224880?
This trial is sponsored by Cytrellis Biosystems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07224880 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07224880's enrollment target sits among peer trials
10 10th of 10 higher than 1 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI